- Home
- NUS
as 11-22-2024 4:00pm EST
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | PROVO |
| Market Cap: | 377.3M | IPO Year: | 1996 |
| Target Price: | $8.88 | AVG Volume (30 days): | 845.2K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -2.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.95 - $20.75 | Next Earning Date: | 11-07-2024 |
| Revenue: | $1,775,172,000 | Revenue Growth: | -11.37% |
| Revenue Growth (this year): | -10.06% | Revenue Growth (next year): | 2.54% |
Latest Nu Skin Enterprises Inc. News
NUS Breaking Stock News: Dive into NUS Ticker-Specific Updates for Smart Investing
Simply Wall St.
15 days ago
Nu Skin Enterprises Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Zacks
16 days ago
Nu Skin Q3 Earnings & Sales Miss Estimates, 2024 Guidance Cut
GuruFocus.com
16 days ago
Nu Skin Enterprises Inc (NUS) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...
Zacks
16 days ago
Nu Skin Enterprises (NUS) Lags Q3 Earnings and Revenue Estimates
Associated Press Finance
16 days ago
Nu Skin: Q3 Earnings Snapshot
StockStory
16 days ago
Nu Skin (NYSE:NUS) Reports Sales Below Analyst Estimates In Q3 Earnings
Business Wire
16 days ago
Nu Skin Enterprises Reports Third Quarter Results
Business Wire
16 days ago
Nu Skin Enterprises Announces Quarterly Dividend
Compare NUS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NUS Nu Skin Enterprises Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.